Skip to main content
. 2026 Jun 18;18(6):682. doi: 10.3390/v18060682
SARS-CoV-2 severe acute respiratory syndrome coronavirus 2
ACE2 angiotensin-converting enzyme 2
PEG poly(ethylene glycol)
DMEM dulbecco’s modified eagle’s medium
FBS fetal bovine serum
MOI multiplicity of infection
DMSO dimethyl sulfoxide
PRA plaque reduction assay
IC50 50 percent inhibitory concentration
MTT 4,5-dimethylthazolk-2-yl)-2,5-diphenyl tetrazolium bromide
SD standard deviation
Cho cholesterol
CC50 50 percent cytotoxicity concentration